Secretion rates and amounts of insulin trigger different responses in gene expression

November 22, 2016

Japanese researchers have found that genes respond differently to the amount and rate of secretions of insulin, a hormone whose malfunction can lead to obesity and diabetes. Some genes express themselves quickly when stimulated by high levels of insulin, while others pick up on low sustained levels of the hormone, and repress themselves instead.

Insulin plays an important role in lowering glucose to regulate blood sugar. The body sustains low-dose levels of insulin at all times, while secretions spike temporarily after meals, creating wavelike fluctuations in the amount of insulin that is secreted and circulating in the bloodstream.

The hormone is also involved in metabolism and other cellular and biological processes by regulating gene expression; but the mechanism by which the amount and temporal patterns of insulin secretions--caused by eating and longer periods of fasting between meals--control the manifestation or repression of genes was not clear.

The team led by University of Tokyo researchers extracted wavelike patterns representing temporal changes in genetic expression, for all genes responsive to insulin stimulation; they worked with cultured cells derived from malignant tumors in rat livers, called FAO cells, that were injected with insulin and used RNA sequencing to measure gene expression.

The scientists found that 278 genes responded to insulin, referring to them as insulin-responsive genes, or IRGs. From these, they identified over 50 genes that are involved in important processes, such as cell metabolism, cell growth, and cell division.

Further experimental analyses and mathematical modeling revealed that the genes responded differently to variations in insulin levels and temporal patterns: IRGs whose gene expression increased with insulin stimulation responded rapidly to high doses, while IRGs whose gene expression decreased with the stimulation reacted to low doses, at a slower response rate.

Furthermore, the researchers confirmed that the response of a subset of IRGs in rat livers, when injected with insulin, dovetailed with the results involving cultured cells.

"Our study shows how temporal changes and doses of insulin control gene expression," says University of Tokyo Professor Shinya Kuroda, a coauthor.

"The method we used can be applied to all biological phenomena for which wavelike patterns representing temporal changes can be obtained," says Kuroda. He continues, "One of the potential uses of this approach is to design therapies using drugs whose release rate can be controlled to effectively treat diseases like type 2 diabetes."
-end-
Journal article:

Takanori Sano, Kentaro Kawata, Satoshi Ohno, Katsuyuki Yugi, Hiroaki Kakuda, Hiroyuki Kubota, Shinsuke Uda, Masashi Fujii, Katsuyuki Kunida, Daisuke Hoshino, Atsushi Hatano, Yuki Ito, Miharu Sato, Yutaka Suzuki, and Shinya Kuroda, "Selective control of up-regulated and down-regulated genes by temporal patterns and doses of insulin," Science Signaling

URL: https://dx.doi.org/10.1126/scisignal.aaf3739

DOI: 10.1126/scisignal.aaf3739

Collaborating institution:

Kyushu University

Links:

Graduate School of Science, University of Tokyo https://www.s.u-tokyo.ac.jp/en/

Graduate School of Frontier Sciences, University of Tokyo http://www.k.u-tokyo.ac.jp/index.html.en

Research contact:

Professor Shinya Kuroda
Department of Biological Sciences, Graduate School of Science, University of Tokyo
7-3-1 Hongo, Bunkyo-ku, Tokyo 113-0033, Japan
Tel: +81-3-5841-4697 (Kuroda), +81-3-5841-4699 (Lab.)
Fax: +81-3-5841-4698
Email: skuroda@bs.s.u-tokyo.ac.jp.

Press officer contact:

Project Specialist Kanako Takeda
Public Relations Office, Graduate School of Science, University of Tokyo
7-3-1 Hongo, Bunkyo-ku, Tokyo 113-0033 Japan
Tel: +81-3-5841-0654
Email: kouhou@adm.s.u-tokyo.ac.jp

Funding:

This work was supported by the Creation of Fundamental Technologies for Understanding and Control of Biosystem Dynamics, CREST from the Japan Science and Technology Agency (JST), by the Japan Diabetes Foundation, and by the Ono Medical Research Foundation. Katsuyuki Yugi was funded by the Japan Society for the Promotion of Science (JSPS) [JSPS Grants-in-Aid for Scientific Research (KAKENHI) grant no. JP15H05582] and by the "Creation of Innovative Technology for Medical Applications Based on the Global Analyses and Regulation of Disease-Related Metabolites," PRESTO from JST. Hiroyuki Kubota was funded by "Elucidation and regulation in the dynamic maintenance and transfiguration of homeostasis in living body," PRESTO from JST.

About the University of Tokyo

The University of Tokyo is Japan's leading university and one of the world's top research universities. The vast research output of some 6,000 researchers is published in the world's top journals across the arts and sciences. Our vibrant student body of around 15,000 undergraduate and 15,000 graduate students includes over 2,000 international students. Find out more at http://www.u-tokyo.ac.jp/en/ or follow us on Twitter at @UTokyo_News_en.

University of Tokyo

Related Diabetes Articles from Brightsurf:

New diabetes medication reduced heart event risk in those with diabetes and kidney disease
Sotagliflozin - a type of medication known as an SGLT2 inhibitor primarily prescribed for Type 2 diabetes - reduces the risk of adverse cardiovascular events for patients with diabetes and kidney disease.

Diabetes drug boosts survival in patients with type 2 diabetes and COVID-19 pneumonia
Sitagliptin, a drug to lower blood sugar in type 2 diabetes, also improves survival in diabetic patients hospitalized with COVID-19, suggests a multicenter observational study in Italy.

Making sense of diabetes
Throughout her 38-year nursing career, Laurel Despins has progressed from a bedside nurse to a clinical nurse specialist and has worked in medical, surgical and cardiac intensive care units.

Helping teens with type 1 diabetes improve diabetes control with MyDiaText
Adolescence is a difficult period of development, made more complex for those with Type 1 diabetes mellitus (T1DM).

Diabetes-in-a-dish model uncovers new insights into the cause of type 2 diabetes
Researchers have developed a novel 'disease-in-a-dish' model to study the basic molecular factors that lead to the development of type 2 diabetes, uncovering the potential existence of major signaling defects both inside and outside of the classical insulin signaling cascade, and providing new perspectives on the mechanisms behind insulin resistance in type 2 diabetes and possibly opportunities for the development of novel therapeutics for the disease.

Tele-diabetes to manage new-onset diabetes during COVID-19 pandemic
Two new case studies highlight the use of tele-diabetes to manage new-onset type 1 diabetes in an adult and an infant during the COVID-19 pandemic.

Genetic profile may predict type 2 diabetes risk among women with gestational diabetes
Women who go on to develop type 2 diabetes after having gestational, or pregnancy-related, diabetes are more likely to have particular genetic profiles, suggests an analysis by researchers at the National Institutes of Health and other institutions.

Maternal gestational diabetes linked to diabetes in children
Children and youth of mothers who had gestational diabetes during pregnancy are at increased risk of diabetes themselves, according to new research published in CMAJ (Canadian Medical Association Journal).

Two diabetes medications don't slow progression of type 2 diabetes in youth
In youth with impaired glucose tolerance or recent-onset type 2 diabetes, neither initial treatment with long-acting insulin followed by the drug metformin, nor metformin alone preserved the body's ability to make insulin, according to results published online June 25 in Diabetes Care.

People with diabetes visit the dentist less frequently despite link between diabetes, oral health
Adults with diabetes are less likely to visit the dentist than people with prediabetes or without diabetes, finds a new study led by researchers at NYU Rory Meyers College of Nursing and East Carolina University's Brody School of Medicine.

Read More: Diabetes News and Diabetes Current Events
Brightsurf.com is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to Amazon.com.